Global HealthTech Proximie has raised £66 million Series C funding to digitise operating rooms.

The London-headquartered company says it is aiming to democratise surgery around the world following the fundraise.

The round was led by Advent Life Sciences and included British Patient Capital. It is the latter’s fourth life sciences deal following previous investments in Microbiotica, Epsilogen and Quell Therapeutics.

Proximie was founded by NHS surgeon Dr Nadine Hachach-Haram with a mission to improve access to quality medical intervention globally. 

After seeing first-hand the discrepancies that can arise between geographies, Dr Hachach-Haram – a fellow of the NHS Clinical Entrepreneur programme – developed Proximie to allow clinicians to virtually ‘scrub in’ to any operating room in the world. 

In turn, the platform enables individuals to share best clinical practice in real-time to support continued medical education.

“Our vision is to democratise surgery through better data by connecting every OR and Cath Lab in the world,” she said. 

“We began this journey enabling surgeons to virtually join any OR. Now, we’re using this capability to digitise the operating room, bringing patients the collective expertise of the best surgeons in the world – where data collected and shared on Proximie can help them receive life-saving care, no matter where they live.”

HealthTechs must move from ‘clicks to bricks’

Judith Hartley, CEO of British Patient Capital, said: “Future Fund: Breakthrough invests in highly innovative, R&D intensive UK companies that are looking to scale up, to help strengthen the UK’s position as a global science superpower. 

“Proximie is driving the future of surgery, helping to improve accessibility to surgical expertise and learning across the globe. 

“Our participation in this round will support Proximie as it continues to  develop its innovative technology, and commercialises its activities around the world.”